Table 1

Baseline characteristics of the control and type 2 diabetic subjects

Control subjects (n = 12)Type 2 diabetic subjects (n = 16)
Sex6M/6F9M/7F
Age, years50.5 ± 2.551.3 ± 2.6
BMI, kg/m228.5 ± 3.129.5 ± 3.3
Duration of diabetes, years5.5 ± 1.3
Fasting plasma glucose, mmol/L4.5 ± 0.37.8 ± 2.2*
HbA1c, %4.8 ± 0.28.4 ± 0.3*
Resting systolic blood pressure, mmHg117.3 ± 5.5123.4 ± 6.4
Resting diastolic blood pressure, mmHg77.5 ± 2.280.2 ± 3.6
Total cholesterol, mmol/L4.5 ± 0.65.1 ± 0.8
Triglycerides, mmol/L0.9 ± 0.21.2 ± 0.4
HDL cholesterol, mmol/L1.4 ± 0.21.2 ± 0.3
LDL cholesterol, mmol/L2.5 ± 0.32.6 ± 0.4
FMD, %11.7 ± 0.75.9 ± 0.6*
Nitrotyrosine, μmol/L0.24 ± 0.050.52 ± 0.03*
8-iso-PGF2a, pg/mL32.6 ± 4.665.0 ± 4.5*
Fasting insulin, pmol/L73.3 ± 4.4107.3 ± 15.2*
  • Data are expressed as means ± SE.

  • *P < 0.001 vs. control subjects.